Successful antibiotic management of Staphylococcus epidermidis endophthalmitis after implantable collamer lens implantation.
Antibiotic therapy
Implantable collamer lens
Postoperative endophthalmitis
Staphylococcus epidermidis
Journal
BMC ophthalmology
ISSN: 1471-2415
Titre abrégé: BMC Ophthalmol
Pays: England
ID NLM: 100967802
Informations de publication
Date de publication:
12 Oct 2023
12 Oct 2023
Historique:
received:
02
03
2023
accepted:
08
09
2023
medline:
2
11
2023
pubmed:
13
10
2023
entrez:
12
10
2023
Statut:
epublish
Résumé
We report a case of successful medical management of endophthalmitis post implantable collamer lens (ICL) culture-positive of Staphylococcus epidermidis. A 18-year-old female presented with decreased visual acuity in the left eye 20 days after ICL implantation. A diagnosis of postoperative endophthalmitis was made based on examination and ultrasonography. A vitreous tap was taken, and intravitreal antibiotics (vancomycin 1 mg/0.1ml and ceftazidime 2 mg/0.1ml) were administered twice (every 72 h), and peribulbar injection of triamcinolone acetonide after four days of the second intravitreal injection. The vitreous culture was confirmed for Staphylococcus epidermidis. The endophthalmitis was resolved, and visual acuity improved from 6/20 to 12/20 on day 7 and 22/20 on day 38. This is the first successful medical resolution of Staphylococcus epidermidis endophthalmitis post ICL surgery without ICL explantation and vitrectomy in the V4c model. In antibiotic therapy, the excellent compliance and close follow-up of this endophthalmitis patient enabled careful postoperative surveillance on the effect of antibiotic therapy, avoiding the removal of the ICL or the loss of the integrity of the eye. The risk of potential infectious endophthalmitis post-ICL surgery should be fully emphasized during preoperative counseling.
Identifiants
pubmed: 37828437
doi: 10.1186/s12886-023-03127-5
pii: 10.1186/s12886-023-03127-5
pmc: PMC10568818
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
410Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Clin Microbiol Rev. 2017 Jul;30(3):597-613
pubmed: 28356323
J Cataract Refract Surg. 2009 Apr;35(4):766-9
pubmed: 19304102
Acta Ophthalmol. 2011 Mar;89(2):e209-10
pubmed: 19925523
Am J Ophthalmol. 2012 Mar;153(3):391-398.e2
pubmed: 22030353
Am J Ophthalmol Case Rep. 2022 Mar 25;26:101500
pubmed: 35372713
Am J Ophthalmol. 2018 Jul;191:76-82
pubmed: 29654738
J Vitreoretin Dis. 2020 Nov 4;5(3):258-260
pubmed: 37006510
Ophthalmol Retina. 2018 May;2(5):396-400
pubmed: 31047321
Front Med (Lausanne). 2023 Feb 27;10:1063003
pubmed: 36936228
BMJ Case Rep. 2015 Nov 24;2015:
pubmed: 26604235
Indian J Ophthalmol. 2017 Dec;65(12):1396-1402
pubmed: 29208820
J Cataract Refract Surg. 2022 Jun 1;48(6):649-656
pubmed: 34653095
Indian J Ophthalmol. 2022 Feb;70(2):362-368
pubmed: 35086198
Ophthalmology. 1997 Feb;104(2):261-72
pubmed: 9052630
J Refract Surg. 2022 Jun;38(6):332-338
pubmed: 35686713
J Cataract Refract Surg. 2009 Oct;35(10):1826-8
pubmed: 19781481